NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,139 filers reported holding NOVARTIS A G in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $359,566 | +0.3% | 3,530 | -0.6% | 0.02% | -26.7% |
| Q2 2023 | $358,432 | +10.4% | 3,552 | +0.6% | 0.03% | +7.1% |
| Q1 2023 | $324,760 | +1.4% | 3,530 | 0.0% | 0.03% | -9.7% |
| Q4 2022 | $320,242 | +19.5% | 3,530 | +0.2% | 0.03% | +6.9% |
| Q3 2022 | $268,000 | -22.3% | 3,522 | -13.6% | 0.03% | +3.6% |
| Q2 2022 | $345,000 | +12.7% | 4,077 | +17.1% | 0.03% | -15.2% |
| Q1 2022 | $306,000 | +0.3% | 3,483 | 0.0% | 0.03% | 0.0% |
| Q4 2021 | $305,000 | +13.8% | 3,483 | +6.1% | 0.03% | 0.0% |
| Q3 2021 | $268,000 | -10.7% | 3,283 | -0.0% | 0.03% | -13.2% |
| Q2 2021 | $300,000 | +24.0% | 3,284 | +15.9% | 0.04% | +8.6% |
| Q1 2021 | $242,000 | -6.6% | 2,834 | +3.1% | 0.04% | -14.6% |
| Q4 2020 | $259,000 | -73.9% | 2,750 | +153.0% | 0.04% | +2.5% |
| Q2 2019 | $992,000 | – | 1,087 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |